Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Fecal Microbiota Transplantation in Reducing Recurrence of Colorectal Adenomas After Endoscopic Resection: a Multicenter, Open-label, Randomized Controlled Study
Conditions
Interventions
fecal microbiota transplantation
Locations
5
China
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Shenzhen Hospital of Southern Medical University
Shenzhen, Guangdong, China
Luohu District People's Hospital
Shenzhen, Guangdong, China
Shenzhen University General Hospital
Shenzhen, Guangdong, China
Shunde Hospital of Southern Medical University
Shunde, Guangdong, China
Start Date
April 9, 2024
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2028
Last Updated
July 15, 2024
NCT03325855
NCT06133387
NCT06359808
NCT07035691
NCT06802276
NCT05692024
Lead Sponsor
Shenzhen Hospital of Southern Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions